Trial Profile
A retrospective study of Albiglutide in patients with Type 2 Diabetes: Real world outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Albiglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Sep 2016 New trial record